A Chance to Try it Out

Jan 27, 2009

The US Food and Drug Administration approved biotech firm Geron's application to conduct a clinical trial of a human embryonic stem cell therapy. The decision came days after President Obama was inaugurated though Geron and FDA representatives say the timing is coincidental.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

People in the News: Tony Serafini-Lamanna, Martin Chavez, Sun Kim, Oved Amitay, More
In Brief This Week: ArcherDX, Sherlock Biosciences, Caris Life Sciences, and More
New Products Posted to GenomeWeb: Aalto Bio Reagents, Thermo Fisher, Oxford Immunotec, More
BioCore, SolGent, Seasun Get FDA Emergency Use Authorizations for Coronavirus Tests
P23 Labs Receives FDA Emergency Use Authorization for SARS-CoV-2 Test
Northern, Southern Italian Populations Began to Diverge Genetically Thousands of Years Ago

The Scan

Letters Urge Review of Decision to End Coronavirus Grant

Nobel laureates and scientific societies urge NIH and the Department of Health and Human Services to revisit the recent decision to end funding for a coronavirus grant.

US Concerns Over BGI Testing in Middle East

Bloomberg reports that BGI's SARS-CoV-2 testing sites in the Middle East have raised concerns among US officials.

Confidence Boost

A new Pew Research Center poll finds confidence in medical researchers has grown among US adults since the start of the coronavirus pandemic.

Science Studies Describe Machine Learning Algorithm to Speed Mendelian Diagnoses, Safe Drug Response Gene, More

In Science this week: machine learning algorithm for faster Mendelian disorder diagnoses, gene linked to safe response to nitrogen-containing bisphosphonates, and more.

Menu